drugset / Trial / NCT00887380

STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing)

NCT00887380

Phase 3 Unknown 2023 enrolled Trans Tasman Radiation Oncology Group
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether starting anastrozole prior to radiotherapy, so that it is taken during radiotherapy, decreases local recurrence of breast cancer in post-menopausal women in comparison to waiting until after radiotherapy to commence anastrozole.

Timeline

Start
2009-09-16
Primary completion
2024-12
Completion
2024-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Anastrozole Other / unclassified 1 mg

Indications